Navigation Links
Financing of biotech companies so far in 2005: A Midwest odyssey

For a biotech company, raising money is a saga that never ends.

Just as you complete a round, you have to do two things: execute on the timely achievement of key milestones you identified for your new investors and look at the structuring of your next financing and where and who the money will come from. Most angel investors aren't repeti......

Full article >>> bove, only two of the companies had a share price above $10 per share, which is one indicator of IPO strength. Aspreva Pharmaceuticals was the only company to have a significant amount of money raised (i.e. above $75 million). So what makes for a successful IPO? It is a combination of factors including:

Market timing
Company credentials
Management team and track record
Pri......

Full article >>> s from a VC panel at the InvestMidwest conference, which was held recently in Kansas City. His remarks were in response to another west coast VC's comment that most biotech companies on the west coast are in a unique situation in that they are getting multiple term sheets for the funding of their deals. This is allowing them to pick the best deal.

Churchwell commented that the situation i......

Full article >>> illion last year (or a decline of 19 percent).

A key indicator for the Midwest biotech sector was VC activity in biotech. The first quarter showed a total of $781 million versus almost $1.4 billion last year (or a decline of 43 percent). Ouch!



Though we don't yet have data to show how the Midwest fared in this area, I'm willing to bet that it ......

Full article >>> lines.

The ramifications of the Bone Care deal are both good and bad for the Midwest. On the downside, there are only 25 publicly traded biotech companies in the Midwest. Two have been picked off this year: Orphan Medical (by Jazz Pharmaceuticals) and now Bone Care (also don't forget Esperion and Cima Labs in 2003).

On the positive side, there are some new multi-millionaire inves......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 05/11/05


Related biology technology :

1. Financing life science: The ongoing saga
2. Seed-Stage Venture Financing
3. Quintessence Secures Financing
4. The state of global biotech: An Ernst & Young perspective
5. Olympics of biotechnology has international flavor
6. Getting noticed in Genetown: Wisconsin biotech on display
7. Madison biotech NimbleGen files for IPO; one of states best-funded firms
8. Wisconsin biotech firm receives $107K NIH grant
9. Manufacturing partnership will move into biotech and biomedical spaces
10. Wisconsin wont get Georgia biotech without a fight
11. The 10 biggest events shaping biotech in 2006
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
Breaking Biology Technology:
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):